P/E ratio for West Pharmaceutical (WST)
P/E ratio as of April 2024 (TTM): 50.2
According to West Pharmaceutical's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 50.2437. At the end of 2022 the company had a P/E ratio of 29.9.
P/E ratio history for West Pharmaceutical from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 29.9 | -43.12% |
| 2021 | 52.6 | -12.96% |
| 2020 | 60.4 | 31.4% |
| 2019 | 46.0 | 31.31% |
| 2018 | 35.0 | -27.26% |
| 2017 | 48.1 | 11.21% |
| 2016 | 43.3 | -4.41% |
| 2015 | 45.3 | 52.23% |
| 2014 | 29.7 | -2.09% |
| 2013 | 30.4 | 31.5% |
| 2012 | 23.1 | 36.36% |
| 2011 | 16.9 | -19.4% |
| 2010 | 21.0 | 17.97% |
| 2009 | 17.8 | 25.02% |
| 2008 | 14.3 | -24.15% |
| 2007 | 18.8 | -23.7% |
| 2006 | 24.6 | 45.63% |
| 2005 | 16.9 | -22.97% |
| 2004 | 22.0 | 93.01% |
| 2003 | 11.4 | -39.39% |
| 2002 | 18.8 | -126.11% |
| 2001 | -71.9 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 10.3 | -79.41% | 🇺🇸 USA |
 Medtronic MDT | 29.1 | -42.05% | 🇮🇪 Ireland |
 Baxter BAX | 7.74 | -84.59% | 🇺🇸 USA |
 Becton Dickinson BDX | 42.0 | -16.39% | 🇺🇸 USA |
 Stryker Corporation SYK | 48.1 | -4.30% | 🇺🇸 USA |
 Teleflex TFX | 24.1 | -52.01% | 🇺🇸 USA |
 ICU Medical
ICUI | -48.0 | -195.48% | 🇺🇸 USA |
 Antares Pharma ATRS | 16.4 | -67.28% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.